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ABSTRACT: 
Granulation is a size enlargement process, in fine or coarse particles converted into physically 
stronger and larger agglomerates having good flow property, better compression characteristics 
and uniformity, prevent segregation of the blend components, improve content uniformity, and 
eliminate excessive amounts of fine particles. Sizeof granules has a size range of 0.2 to 4.0 mm, 
depending on their subsequent use. Size of the granules depends on the quantity and feeding rate 
of granulating liquid.  
The selection of process to prepare granules requires thorough knowledge of physicochemical 
properties of the drug, excipients, required flow and release properties, to name a few.  
At current scenario available technologies includes, spray drying, roller compaction, high shear 
mixing, and fluid bed granulation etc.  
The objective of present work is to focus on the commonly usedand novel granulation 
technologies like such as pneumatic dry granulation, steam granulation, moisture-activated dry 
granulation, thermal adhesion granulation, freeze granulation, and foamed binder or foam 
granulation. 
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Granulation Technology is the art and science for process and production of granules in which 
primary powder particles are made to adhere to form larger, multiparticle entities called 
granules
1
. Granules are used in production of tablets orcapsules, when granules are prepared as 
an intermediate product and having size range between 0.2 and 0.5 mm, but larger granules are 
used as a dosage form in their own right
2
.  
Granulation process commences after dry mixing of the necessary powder ingredients along with 
drug to achieve uniform distribution of each ingredient throughout the powder mixture. 
Agglomerated granules are formed by solid bridges, sintering, chemical reaction, crystallization 
and deposition of colloidal particles
3
.  
After granulation the granules either packed, or they may be mixed with other excipients before 
tablet compaction or capsule filling. 
The effectiveness of granulation depends on particle size of the drug and excipients, type of 
binder, volume of binder, wet massing time (less or more), amountof shear applied, drying rate 






1. To avoid segregation of the constituents. 
2. To improve the flow properties of the mixture. 
3. To improve the compaction of the powder. 
4. The granulation of toxic materials avoid hazard of toxic dustthat may arise when handling 
powders.  
5. To avoid formation of cake in hygroscopic substances.  
6. Granules occupy less volume per unit weight so more convenient for storage or shipment. 
7. To improve appearance of the product. 
 8. To improve compression properties of the mixture. 
Ideal characteristics of granules
8
 
 It should have spherical shape for improved flow 
 It should have narrow particle size distribution for contentuniformity and volumetric 
dispensing, sufficient fines to fill void spaces between granules for better compaction and 
compression characteristics,  
 It should have adequate moisture and hardness to prevent breaking and dust formation 
during process.  
Methods of granulation: 
A. Dry granulation    B.  Direct compression   C. Wet granulation 
A. Dry granulation
9, 10 
In dry granulation process the powder mixture is compressedwithout the use of heat and solvent. 
The primary powder particles are aggregated under high pressure. There are two main processes- 
i) Slugging-  Either a large tablet known as a ‘slug’ is produced in a heavy-duty tabletting press 
ii) Roller compaction or the powder is squeezed between two rollers to produce a sheet of 
material. 
In both cases these intermediate products are broken using a suitablemilling technique to produce 
granular material, which is usually sieved to separate the desired size fraction. Steps involved in 
dry granulation process are 
1. Milling of drugs and excipients 
2. Mixing of milled powders 
3. Compression into large, hard tablets to make slug 
4. Screening of slugs 
5. Mixing with lubricant and disintegrating agent 
6. Tablet compression 
Advantages: 
1. It uses less equipments and space.  
2. It eliminates the need for binder solution, heavy mixingequipment and the costly and time 
consuming drying step required for wet granulation.  
3. Slugging can be advantages for moisture and heat sensitive materials and improved 
disintegration since powder particles are not bonded together by a binder. 
Limitations- 
1. It requires a specialized heavy-duty tablet press to form slug.  
2. It does not permit uniform color distribution as can beachieved with wet granulation where the 
dye can be incorporated into binder liquid.  




This method is used when ingredients can be blended and placed in a tablet press to make a 
tablet without any of the ingredients having to be changed. However this is not very common 
because many tablets have active pharmaceutical ingredients which will not allow for direct 
compression due to their concentration or the excipients used in formulationare not contributory 
to direct compression 
Direct compression involves following steps: 
1. Milling of drug and excipients 
2. Mixing of drug and excipients 
3. Tablet compression 
Advantages- 
 1. It is more economic since the direct compression requires few unit operations. 
2. More suitable for moisture and heat sensitive drugs. 
3. The tablets prepared by direct compression exhibits comparativelyfaster dissolution.  
4. Less wear and tear of punches. 
Disadvantages: 
1. Capping, lamination, splitting, or layering of tablets is sometimes related to air entrapment 
during direct compression.  
2. When air is trapped, the resulting tablets expand when the pressure of tablet is released, 
resulting in splits or layers in the tablet.  
3. In some cases, require greater sophistication in blending andcompression equipments. Direct 




Wet granulation process involves wet massing of the powder blend with a granulating liquid, wet 
sizing and drying. The fluid contains a solvent which must be volatile sothat it can be removed by 
drying, and be non-toxic. Typical liquids include water, ethanol and isopropanol, either alone or 
in combination. 
Steps involved in the wet granulation 
1. Mixing of the drugs and excipients 
2. Preparation of binder solution 
3. Mixing of binder solution with powder mixture to form wet mass. 




1. It allows mechanical handling of powders without loss of quality of blend. 
2. The flow properties of powder are improved by increasing particle size and sphericity. 
3. Increases and improves the uniformity of powderdensity. 
4. Improves cohesion during and after compaction. 
5. There is reduction of air entrapment. 
6. Less dust and cross contamination. 
7. The hydrophobic surfaces are made hydrophilic. 
Limitations of wet granulation: 
1. It is an expensive process because of labor, time, equipment, energy and space requirements. 
2. Loss of material during various stages of processing 
 3. Not suitable for moisture sensitive or thermo labile drugs 
4. It involves multiple processing steps add complexity and make validation and control difficult 
 5.  Incompatibility between formulation components is aggravated. 
ADVANCED GRANULATION TECHNIQUES- 
1.  Melt agglomeration/ thermoplastic granulation
14
: 
This technique consists of the agglomeration of powder particles using binders that, which melts 
or softens at relatively low temperature (50–90 °C). Solid fineparticles are bound together into 
agglomerates by agitation, kneading, and layering in the presence of molten binding liquid.  
 After cooling of the agglomerated powder and the consequent solidification of the molten or 
soften binder complete the formation of the granules.  
It utilizes two methods one is spray on method that involves spraying of the molten binder onto 
the powder and by simple cooling of the product at room temperature followed by milling to 
obtain dried granules. Another one is in situ melt granulation method that employs a solid binder 
which is heated above its melting point by hot air, when it is processed in fluidized bed 
processor.  
 Advantages: 
1. No requirement of any solvent either aqueous or non-aqueous. 
2. Less time consuming and economical process. 
3. Uniform dispersion of fine particle. 
4. Release profile of drugs can be controlled and modified. 
5. Suitable for enhancing dissolution profile and bioavailabilityof poorly water soluble drugs by 
forming solid dispersion. 
6. Improved product stability. 
Disadvantages: 
1. Not suitable for thermo-labile materials. 
2. There is need of high energy input. 
3. During handling and storage of agglomerates melting or softening of binder may occur. 
(2) Foam granulation
15 
This technique is analogous to spray agglomeration; it involves the addition of liquid/aqueous 
binder as foam instead of spraying or pouring liquid onto the powder particles.Adding the binder 
solution as foam rather than a spray eliminates the problems of inconsistent and unpredictable 
binder distribution that can affect tablet hardness and drug release.  
A foam generator is used in the binder solution tank with high-shear granulator or fluid bed 
granulator to introduce the binder as foam rather than spraying or pouring in binder onto the 
moving powder particles.  
Advantages- 
1. No need of spray nozzle. 
2. Less water required  
3. Economical process 
4. Suitable for water sensitive formulations. 





This technique enables preservation of the homogeneity from suspension to dry granules. By 
spraying a powder suspension into liquid nitrogen, the drops are instantly frozen into granules, 
and by freeze drying process, the granules are dried by sublimation of ice without any 
segregation effects. The result will be spherical, free flowinggranules, with optimal 
homogeneity. 
Advantages- 
1. Granule density can be controlled by the solids content of the suspension. 
2. Cavities in the granules can be avoided. 
 3.  High yield, less wastage of material. 
3. Easy cleaning of equipments. 
4. Organic solvents can be recycled. 
 (4) Moisture activated dry granulation
17 
This technique is a variation of conventional wet granulation technique. This technology is 
widely used in granulation of moisture sensitive active pharmaceutical ingredients. This process 
involves the utilization of very little granulating fluid, to activate granule formation and it also 
eliminates the drying steps by using moisture absorbing materials like microcrystalline cellulose, 
potato starch, a mixture of MCC and potato starch (50% w/w to removeexcess of moisture 
present in the granulate. The moisture absorbents absorb the moisture from the agglomerates, 
resulting in moisture redistribution within the powder mixture, leading to relatively dry granule 
mixture. 
This process is accomplished by two major steps agglomeration and moisture distribution. It 
involves the formation of wet mass by using granulating fluid and then utilizing the moisture 
absorbing materials to dry the granules.  
Advantages: 
1. A simple, clean, lean process that utilizes very little granulating fluid. 
2. Produce granules with more uniform particle size distribution (particle size range of 150–500 
μm) and excellent flowability. 
3. Economical and time efficient, as requires less energy andeliminates drying step. 
4. Suitable for continuous processing. 
5. Used for preparation of floating and sustained release products. 
6. Applicable to more than 90% of the granulation need for pharmaceutical, food and Nutritional 
industry. 
Disadvantages: 
1. Unsuitable for thermo-labile, moisture sensitive, high moisture absorbing substances. 
2. Formulations with high drug loading are difficult to develop. 
 




Figure 2: Extrusion Spheronizer 
 
This technique involve in production of  granules or pellets of uniform sizewith high drug 
loading capacity. It consist of multiple steps of wet mass extrusion followed by spheronization to 
produce uniform sized spherical particles with narrow size distribution.  
It is mainly used in multi particulates for oral controlled drug delivery system.  
 Steps involved in extrusion-spheronization process: 
a. Dry mixing of materials for homogeneous dispersion. 
b. Wet granulation of the mixture to form wet mass. 
c. Extrusion of wet mass to form rod shaped particles. 
d. Rounding off the rod shaped particles using spheronizer. 
e. Drying. 
Advantages: 
a. Suitable for  higher levels of active ingredients without production of larger particles. 
b. Suitable for combination of two or more active agents within the same unit, in any ratio. 
c. It produces spherical particles with high bulk density, low hygroscopicity, narrowparticle size 
distribution and smoother surface. 
Disadvantages: 
1. Time consuming process having requirement of more labour. 
2. Moisture sensitive and thermo-labile materials are not suitable candidates for it. 
(6) Fluidized bed granulation
19
: 
It is an air suspension technique in which binder solution is sprayed on to the fluidized powder 
bed in order to get finer, free flowing and homogenous granules. Thisfluidized bed processor 
contains air handling unit, product container, air distributor, spay nozzle, disengagement area, 
process filters, exhaust blower/fan, control system, and solution delivery systems. 
The particle formation in fluidized bed granulation is influenced by numerous parameters like 
moisture content in solids, liquid spray flow rate, airflow rates, and atomization pressure. 
Granulation in fluidized state can be achieved either by batch process or continuous process. For 
granulation in batch process, the dry starting product is placed in the product container, where it 
is mixed vigorously in the heated gas stream, held in the suspension and granulated by spraying 
with a suitable bonding material. The product is finally dried to therequired end moisture 
content.  
(7) Spray drying granulation
20
: 
This process is used to produce microcapsules, food ingredients, flavors and various 
biotechnological preparations. Dry granular product is obtained by feeding a solution of active 
agent along with excipients into the drying system, where the feed is atomized and dried with a 
heated gas stream followed by separation of granular product from the gas stream.  This process 
differs from other methods in that it is a continuous process inwhich a dry granular product is 
made from a solution or a suspension rather than initially dried the primary powder particles. 
The spray drying process involves three fundamental steps, 
1. Liquid feed’s atomization into fine droplets 
2. Mixing of sprays droplets with a heated gas stream, for liquid evapoarion.  
3. Separation of the dried powder from the gas stream. 
Advantages: 
1. It is a rapid and continuous process 
2. It reduces overall cost by eliminating labor intensive drying and granulation steps. 
3. Less exposure to dust. 
4. Heat sensitive product are suitable candidates. 
(8). Steam granulation 
  
Steam granulator 
This process is simply a modification of conventional wet granulation method. In this technique, 
water steam is used as binder. Pure form of steam is transparent gas,and it provides a higher 
diffusion rate into the powder and a more favorable thermal balance during the drying step. At 
standard temperature and pressure, pure steam (unmixed with air, but in equilibrium with liquid 
water) occupies about 1,600 times the volume of an equal mass of liquid water. After 
condensation of the steam, water forms a hot thin film on the powder particles, requiring only a 
small amount of extra energy for its elimination, and evaporates more easily. 
Advantages: 
1. Results in more spherical granule formation 
2. Higher diffusion rate 
3. Environment friendly, safe forworking operator. 
4. Maintain sterility 
Disadvantages: 
1. There is need of special equipment for steam generation and transportation. 
2. Need of high energy inputs 
3. Not suitable for thermo labile materials. 
(9). Thermal adhesion granulation: 
This technique was developed by Wei-Ming Pharmaceutical Company (Taipei, Taiwan). It 
involves granulation of the blend by addition of very less amount of water or solvents. 
This technique is quite simple and convenient with low moisture and binder contents in a closed 
system for preparing highly compressible materials or for modifying the poor characteristics of 
excipients. 
 In this process the binder is first moisturized by spraying water or ethanol, and then this blend is 
transferred into a pre warmed glass bottle and sealed. It is then heated properly by an infrared 
lamp to raise surface temperature of the vessel to 90ºC-105ºC in case of water and 70ºC-90ºC in 
case of ethanol, and mixed under tumble rotation for 3-20 minutesuntil the granules are formed. 
Thermal adhesion granulation process is performed under low moisture content or low content of 
pharmaceutically acceptable solvent by subjecting a mixture of excipients to heating. This 





1. Utilizes less amount of water or solvent. 
 2. Granules with good flow properties and binding capacity were obtained even with substances 
having poor tabletting properties. 
3. Minimizes the dust generation during powder processing. 
(10) Pneumatic dry granulation
22
: 
This method involves production of granules from powder particles by initially applying mild 
compaction force by roller compactor to produce a compacted masscomprising a mixture of fine 
particles and granules. To separate the granules and to recycle the rejected fraction, a newly 
innovated fractionating device is employed. Granules pass through the fractioning chamber to be 
compressed into tablets. Pneumatic dry granulation is suitable for automatic or semi-automatic 
production of granules. 
Advantages: 
a. High drug loading is possible. 
b. Faster development (within weeks). 
c. Suitable for thermo-labile and moisture sensitive drugs. d. Improvedstability with increased 
shelf-life. 
e. Compatible with other technologies like coating, sustained release. 
f. Produce soft and porous granules with improved flow property and compressibility. 
g. Taste masking can be achieved. 
h. Sterile products and toxic materials can be handled.  
i. Reduces cost of final product by minimizing waste through recycling and production cost. 
 
Characterization methods of granules. 
S.N. Parameters Method 
1.  Particle  morphology Optical microscopy 
2.  Granule flow ability and density Density apparatus, mechanical and Hopper method 
3.  Particle size distribution Sieve analysis, laser light scattering 
4.  Granule porosity Mercury intrusion methods 
5.  Thermal analysis DTA, TGA, DSC 
6.  Nature Powder X-ray diffraction 
7.  Identification Near-Infrared spectroscopy (NIR) 
8.  Surface area Gas adsorption 
 
CONCLUSION: 
Granulation is one of the most important unit operations in the production of pharmaceutical 
dosage forms. It is used to prevent segregation of formulation components in a powder blend, 
bulk volume of granulation, improve blend flow, content uniformity, compressibility, and other 
properties.  
In pharmaceutical industry, tablets are manufactured by either of the three methods viz. direct 
compression, wet granulation, dry granulation. Each technique has its own advantage and 
disadvantages. Selection of correct granulation method depends on the ingredients individual 
characteristics and ability to properly flow, compresses, eject, and disintegrate.Choosing a 
method requires thorough investigation of each ingredient in the formula, the combination of 
ingredients, and how they work with each other.  
Selection of appropriate technology for carrying out the granulation process is the key to achieve 
a targeted granulation and final product parameters. So, depth knowledge of the processing 
 techniques and their merits and demerits is required to adopt duringdevelopment stage of 
product.  
This review discussed the recent developments in granulation technology; it may be beneficial 
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